{"id":"W1975929001","doi":"10.1111/dom.12121","title":"Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( <scp>GetGoal</scp> ‐P)","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"American Diabetes Association","keywords":"Lixisenatide; Placebo; Medicine; Pioglitazone; Internal medicine; Adverse effect; Metformin; Type 2 diabetes; Randomized controlled trial; Clinical endpoint; Diabetes mellitus; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002083253,0.0008724299,0.003439096,0.0005743196,0.0003488939,0.00104911,0.0006820516,0.001901923,0.003581228],"category_scores_gemma":[0.002352987,0.0006404781,0.001492884,0.000407396,0.0008469445,0.001130835,0.000392763,0.001726188,0.0004209011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004849792,"about_ca_system_score_gemma":0.0006237309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003355526,"about_ca_topic_score_gemma":0.0004849029,"domain_scores_codex":[0.9989396,0.0005891284,0.0001412893,0.0001481627,0.0001066567,0.00007520941],"domain_scores_gemma":[0.998385,0.0005675746,0.0004675466,0.00009290806,0.00007404466,0.0004130072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9718199,0.006498947,0.000541122,0.0005927545,0.0005507065,0.00002187334,0.00003067395,0.0001265228,0.004805882,0.0000340039,0.0001095089,0.01486798],"study_design_scores_gemma":[0.7344097,0.2586835,0.003444268,0.00007321669,0.0007921861,0.00004568772,0.00003318082,0.0004308085,0.001672963,0.00008415399,0.0003110884,0.00001912005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920946,0.005983243,0.0002400503,0.0002180674,0.0002268275,0.0005012281,0.0001905218,0.00004660952,0.0004988431],"genre_scores_gemma":[0.994787,0.002356262,0.0006969579,0.0003170368,0.0002336362,0.0007027427,0.0002171385,0.000009489311,0.0006797388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003581228,"threshold_uncertainty_score":0.01198041,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009655752413255798,"score_gpt":0.2276453307407597,"score_spread":0.2179895783275039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}